Speaker
Sally John, Ph.D.
Biogen
Sally John, PhD, is the Head of Translational Biology within Research and Development (R&D) at Biogen. She joined Biogen in 2014 as Vice President of the Genetics and Computational Biology groups, She is committed to increasing the probability of success in R&D through the use of human genetics combined with robust translational pre-clinical models and end-points. She has held roles of increasing responsibility within Research in AstraZeneca and Development in Pfizer. Sally has a PhD in Molecular Biology from the University of Manchester, UK and post-doctoral training in Genetic Epidemiology. P